EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

MitoEVs: A new player in multiple disease pathology and treatment

Xiyue Zhou, Shuyun Liu, Yanrong Lu, Meihua Wan, Jingqiu Cheng, Jingping Liu iD

Journal of Extracellular Vesicles · 2023-04 · 12 (4)

DOI: 10.1002/jev2.12320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 31.03.2023. Verfasst von Xiyue Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sic…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial damage plays vital roles in the pathology of many diseases, such as cancers, neurodegenerative diseases, aging, metabolic diseases and many types of organ injury. However, the regulatory mechanism of mitochondrial functions among different cells or organs in vivo is still unclear, and efficient therapies for attenuating mitochondrial damage are urgently needed. Extracellular vesicles (EVs) are cell‐derived nanovesicles that can deliver bioactive cargoes among cells or organs. Interestingly, recent evidence shows that diverse mitochondrial contents are enriched in certain EV subpopulations, and such mitoEVs can deliver mitochondrial components to affect the functions of recipient cells under different conditions, which has emerged as a hot topic in this field. However, the overview and many essential questions with respect to this event remain elusive. In this review, we provide a global view of mitoEVs biology and mainly focus on the detailed sorting mechanisms, functional mitochondrial contents, and diverse biological effects of mitoEVs. We also discuss the pathogenic or therapeutic roles of mitoEVs in different diseases and highlight their potential as disease biomarkers or therapies in clinical translation. This review will provide insights into the pathology and drug development for various mitochondrial injury‐related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesNeoplasmsHumansMitochondriaProtein TransportCell Communication

Stichwörter der Autor:innen

extracellular vesicleimmune responsemetabolismmitoEVmitochondria

Autor:innen und Institutionen

  • NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Jingping Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, X., Liu, S., Lu, Y., Wan, M., Cheng, J., & Liu, J. (2023). MitoEVs: A new player in multiple disease pathology and treatment. Journal of Extracellular Vesicles, 12(4). https://doi.org/10.1002/jev2.12320

Vancouver

Zhou X, Liu S, Lu Y, Wan M, Cheng J, Liu J. MitoEVs: A new player in multiple disease pathology and treatment. Journal of Extracellular Vesicles. 2023;12(4). doi:10.1002/jev2.12320

BibTeX
@article{Zhou2023,
  author = {Zhou, Xiyue and Liu, Shuyun and Lu, Yanrong and Wan, Meihua and Cheng, Jingqiu and Liu, Jingping},
  title = {MitoEVs: A new player in multiple disease pathology and treatment},
  journal = {Journal of Extracellular Vesicles},
  year = {2023},
  volume = {12},
  number = {4},
  doi = {10.1002/jev2.12320}
}
Kostenlos starten →